SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?


To: Exacctnt who wrote (1774)5/11/2001 4:11:32 PM
From: Thure Meyer  Read Replies (1) | Respond to of 1837
 
Not so great if you look at their growth.

At the current revenue growth rate, this company will be worth a lot more than $14.-/share
I prefer if they execute their company strategy for a couple of years.

Thure



To: Exacctnt who wrote (1774)5/11/2001 9:14:41 PM
From: Knighty Tin  Respond to of 1837
 
Ex, You are welcome. I am hyperventilating at $9. $14 may force me to go use Vaso's EECP therapy. <g>